{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.408","value":"-16.98"},{"groupId":"OG001","spread":"14.628","value":"-14.94"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"84"}],"units":"Participants"}],"title":"Hemoglobin Month 1"},{"categories":[{"measurements":[{"comment":"insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"-25.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Hemoglobin Month 2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.013","value":"-30.83"},{"groupId":"OG001","spread":"19.410","value":"-15.78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"72"}],"units":"Participants"}],"title":"Hemoglobin Month 3"},{"categories":[{"measurements":[{"comment":"insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"-22.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Hemoglobin Month 4"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.935","value":"-6.80"},{"groupId":"OG001","spread":"19.755","value":"-3.16"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"Hemoglobin Month 6"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.242","value":"0.36"},{"groupId":"OG001","spread":"15.632","value":"-0.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"60"}],"units":"Participants"}],"title":"Hemoglobin Month 9"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.598","value":"6.17"},{"groupId":"OG001","spread":"15.417","value":"3.32"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"59"}],"units":"Participants"}],"title":"Hemoglobin Month 12"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.592","value":"11.37"},{"groupId":"OG001","spread":"12.854","value":"7.38"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"52"}],"units":"Participants"}],"title":"Hemoglobin Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.996","value":"13.88"},{"groupId":"OG001","spread":"16.986","value":"7.38"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"45"}],"units":"Participants"}],"title":"Hemoglobin Month 24"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.978","value":"14.41"},{"groupId":"OG001","spread":"12.417","value":"13.63"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"title":"Hemoglobin Month 36"}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"84"}],"units":"Participants"}],"description":"Change from baseline in hemoglobin. Baseline value will be defined as the last value on the randomization date (+3 days) or before the date/time of randomization (date if date/time not collected).","dispersionType":"Standard Deviation","groups":[{"description":"3 cycles of standard of care (SOC) salvage therapy (R-DHAP, R-ICE and R-GDP) per physician's choice. Participants responding to SOC are expected to undergo high dose chemotherapy (HDCT) and hematopoietic stem cell transplant (HSCT). If requested by the investigator, participants may be allowed to receive JCAR017 upon meeting progression, relapse, or suboptimal response. 1 cycle = 3 weeks","id":"OG000","title":"Standard of Care Arm"},{"description":"\\[Lymphodepleting chemotherapy (LDC)\\] Fludarabine IV (30 mg/m\\^2/day for 3 days) and cyclophosphamide IV (300 mg/m\\^2/day for 3 days) followed by JCAR017 IV infusion at a dose of 100 x 10\\^6 JCAR017-positive viable transduced T cells (CAR+ T cells) on Day 29 (2 to 7 days after completion of LD chemotherapy)","id":"OG001","title":"Liso-cel Arm"}],"paramType":"MEAN","populationDescription":"All treated participants with a baseline value and a post-baseline value at the time point","reportingStatus":"POSTED","timeFrame":"baseline, months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36","title":"Change From Baseline in Hematology Parameters 1: Hemoglobin","type":"SECONDARY","unitOfMeasure":"g/L"}